Corporate News 20-Jun-18
Unichem settles patent dispute for generic tadalafil (Cialis®)
Unichem Laboratories has entered into a settlement agreement with Eli Lilly & Company and ICOS Corporation to resolve their patent litigation in the United States District Court for the District of New Jersey regarding Unichem's Abbreviated New Drug Application for generic tadalafil (Cialis®). Under the settlement agreement, Unichem expects to launch its generic tadalafil product in the United States on or not before 26 March 2019 under certain circumstances
Previous News
Unichem Laboratories reports consolidated net loss of Rs 11.49 crore in the June 2021 quarter
( Results - Announcements 31-Jul-21 15:01 )
Unichem Laboratories reports consolidated net profit of Rs 83.99 crore in the December 2023 quarter
( Results - Announcements 05-Feb-24 14:52 )
Unichem Laboratories reports consolidated net loss of Rs 14.10 crore in the December 2021 quarter
( Results - Announcements 29-Jan-22 15:59 )
Board of Unichem Laboratories recommends final dividend
( Corporate News - 28-May-22 16:35 )
Unichem Laboratories receives approval from USFDA for hydrocloride tablets
( Corporate News - 07-May-19 12:21 )
Unichem Laboratories AGM scheduled
( Corporate News - 23-Jun-21 19:48 )
Unichem Labs gets US FDA nod for bipolar treatment drug
( Hot Pursuit - 28-Feb-22 11:58 )
Unichem Laboratories receives reaffirmation in ratings for LT bank facilities
( Corporate News - 26-Nov-21 12:53 )
Unichem Laboratories reports consolidated net loss of Rs 22.21 crore in the September 2019 quarter
( Results - Announcements 04-Nov-19 13:31 )
Unichem Laboratories receives USFDA approval for Cyclobenzaprine HCI Tablets
( Corporate News - 07-Jul-20 15:08 )
Unichem Laboratories approval from USFDA to market generic products
( Corporate News - 07-May-19 12:07 )
Other Stories
Tinna Trade raises Rs 49 cr to fund its growth plans
06-Jul-24 11:10
Integra Essentia announces merger with G G Engineering
06-Jul-24 11:05
Ugro Capital to raise Rs 75 cr via NCD issuance
06-Jul-24 10:58
Board of D.P. Abhushan approves preferential allotment of shares and warrants
06-Jul-24 10:50
Life Insurance Corporation of India invest Rs 14 cr in Sri Lankan subsidiary
06-Jul-24 10:49
High Energy Batteries (India) to discuss results
06-Jul-24 10:29
Havells India schedules board meeting
06-Jul-24 10:29
Axis Bank announces board meeting date
06-Jul-24 10:29
Mastek to conduct board meeting
06-Jul-24 10:29
Oriental Hotels to conduct board meeting
06-Jul-24 10:29
Back
Top
